Claudio Bucolo

Associate Professor of Pharmacology [BIO/14]
Membership Section: Pharmacology
Office: Torre Biologica, 5° piano Torre Sud, stanza 25
Phone: 095 4781196
Office Hours: Tuesday and Thursday from 10:00 to 12:00

Claudio Bucolo is associate professor of Pharmacology at the University of Catania and holds the position of Visiting Professor at the Eye Research Institute of Oakland University (Rochester, MI, USA).

He was the first Italian to receive the international award "Dr. Roger Vogel Award for Pharmaceutical Research 2015 "for the significant contribution in the field of drug research for the treatment of ophthalmic diseases. In 2014 he obtained the "Silver Fellow Medal" of the Association for Research in Vision and Ophthalmology. The research lines of Professor Bucolo mainly concern the field of ocular pharmacology and neuropharmacology. Professor Claudio Bucolo is author of more than 130 scientific articles published in peer-reviewed journals and book chapters.

During his career he has registered 9 international patents in the field of pharmacological research. He is referee of MIUR and Agence National de la Recherche projects and he is Associate Editor of scientific journals in the field of pharmacology. From 2012 to 2013 he was President of the Pharmacology Section of the Annual Meeting Program Committee  ARVO meeting (Association for Research in Vision and Ophthalmology, Rockville, MD, USA), which has about 12750 members and he was re-elected in 2016 as a member of the Program Committee; from May 2018 until May 2019 he holds the role of President of the Pharmacology Section of the Annual Program Committee of ARVO; from 2004 to 2008 he was Board of Trustee of the Association for Ocular Pharmacology and Therapeutics. Moreover, he organized, for several years, a series of Lectio Magistralis in the field of Ocular Pharmacology (European Frontiers in Ocular Pharmacology) delivered by outstanding scientists and the annual IT-ARVO meeting on ocular pharmacology.

Professor Bucolo is currently Board of Trustee of Unifarm University Consortium and BIOMETEC delegate at Superior Graduate School of Excellence University of Catania.

From 2017 Professor Bucolo is Director of Center for Research in Ocular Pharmacology (CERFO) at University of Catania.

He earned the National Scientific Qualification as Full Professor in April 2017.

Claudio Bucolo is associate professor of Pharmacology at the University of Catania and holds the position of Visiting Professor at the Eye Research Institute of Oakland University (Rochester, MI, USA).

Education: Professor Claudio Bucolo received his PhD in Neuropharmacology at the University of Catania associated with Université Bordeaux (France), defending a thesis entitled "Neuroactive steroids and sigma receptors: implications for retinal neuroprotection". Prof. Claudio Bucolo has achieved three M.Phil.: General Pathology, Pharmacognosy and Pharmacology (Magna cum Laude).

He graduated in Pharmacy Magna cum Laude in 1987 at the University of Catania defending a thesis entitled "Correlations between histamine and catecholaminergic system on temperature control in rats". From 1991 to 1993 he worked as Visiting Scholar at Oakland University (Rochester, MI, USA).

Teaching Activity: Professor Bucolo is a member of the Faculty Committee of the International PhD Program in Neurosciences. Taught Pharmacology MD Program; Taught Ocular Pharmacology - Doctor of Optometry Program; Taught Pharmacology - Undergraduate Program in Biomedical Lab Technician; Taught Ocular Pharmacology - Ophthalmology Residency Program.

Grants: Professor Bucolo is PI of several research programs financed by private and Government sources.


view the publications
N.B. the number of publications can affect the loading time of the information






The major research activities of Professor Claudio Bucolo are based on ocular pharmacology and neuropharmacology, In particular, Professor Bucolo studies new pharmacological targets in order to discover novel molecules to treat serious ocular pathologies such as diabetic retinopathy, glaucoma and retinal degeneration.